Company news

Amarantus Bioscience Holdings, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Amarantus Signs Non-Binding Term Sheet to Divest Cutanogen Corporation in Exchange for the Extinguishment of Potential $21M+ in Liabilities

April 26, 2022

Todos Medical Enters Into COVID-19 PCR Testing Implementation and Equipment Financing Partnership with AID Genomics

September 25, 2020

Todos Medical Expands Existing Contract for COVID-19 PCR Testing Equipment & Supplies with Wisconsin-based Laboratory to $47.5 Million

September 22, 2020

3CL Protease Inhibitor NLC-001 Added to COVID-19-focused Joint Venture Between Todos Medical and NLC Pharma

September 17, 2020

Todos Medical Expands Partnership with Care G.B. Plus for Proprietary TBIA Cancer Tests to Include Europe, Israel and Africa

September 16, 2020

Todos Medical Announces August Sales of $1,190,000, Up 100% Compared with July

September 3, 2020

Todos Medical Announces $23,760,000 Contract for COVID-19 PCR Testing Equipment & Supplies With Wisconsin-based Laboratory

August 31, 2020

Todos Medical Appoints Marsha Fontanive as VP of Sales and Chris Gross as VP of Sales Operations

August 25, 2020

Todos Medical Announces $1.2 Million Contract for COVID-19 PCR Testing Equipment & Supplies with Texas-based Laboratory

August 24, 2020

Todos Medical Announces $6,000,000 Contract for COVID-19 PCR Testing Equipment & Supplies with New York-based Laboratory

August 21, 2020

Todos Medical Acquires Distribution Rights to SARS-CoV-2 Rapid Point-of-Care Antigen Test and Rapid Point-of-Care PCR Test

August 14, 2020

UPDATE: Todos Medical Announces Common Stock Purchase Agreement with Lincoln Park Capital Fund, LLC

August 10, 2020

Todos Medical Announces July Sales of COVID-19 Tests

August 7, 2020

Todos Medical Announces Common Stock Purchase Agreement with Lincoln Park Capital Fund, LLC

August 6, 2020

Todos Medical Appoints Dr. Jorge Leon as Consulting Chief Medical and Scientific Officer of Infectious Disease and Oncology

August 4, 2020

Pathnova Laboratories (PATHNOVA) Enters into Partnership to Commercialize Todos Medicals COVID-19 and Breast Cancer Tests in Singapore

August 3, 2020

Todos Medical Completes Acquisition of Breakthrough Diagnostics, Gains Full Rights to the Alzheimer’s Blood Diagnostic LymPro™ Test from Amarantus

July 28, 2020

Todos Medical Announces SARS-nCoV-19 Testing Kit Contract with NJ-Based Best Supply Clinical Laboratory

July 27, 2020

Todos Medical Announces ANVISA Authorization in Brazil for 3D Med qPCR Kits and ANDis Extraction S

July 16, 2020

Todos Medical Enters Into Cross-Distribution Agreement With L1 Systems for Ventilators and COVID Testing

May 26, 2020

Todos Medical Announces First Commercial Sale of COVID-19 Antibody Tests

May 18, 2020

Todos Medical Enters Into Direct Exclusive Distribution Agreement With Gnomegen and Announces US FDA Emergency Use Authorization for its COVID-19 qPCR Test Kits

May 11, 2020

Emerald Organic Products Restructures Joint Venture Agreement With Todos Medical by Entering Joint Collaboration Agreement

May 8, 2020

Todos Medical Announces Positive Data for Serology Point-of-Care Fingerprick Antibody Test Kits

April 28, 2020

Todos Medical Announces US FDA Emergency Use Authorization Allowed for Gnomegen COVID-19 PCR Test Kits

April 21, 2020

Todos Medical Achieves Medical Importer Status with US FDA

April 15, 2020

Todos Medical Expands on Coronavirus (COVID-19) Distribution Agreement with Shanghai Liangrun Subsidiary Gibraltar

March 30, 2020

Coronavirus (COVID-19)-Focused Joint Venture Formed Between Emerald Organic and Todos Medical to Supply U.S. Market With Rapid Point-of-Care Screening and Confirmatory Testing Kits

March 24, 2020

Todos Medical and 3DMed Enter Into Coronavirus (COVID-19) and Influenza A/B Testing Kit Distribution Agreement in US and Israel

March 17, 2020

UPDATE: Todos Medical Enters Into Coronavirus Nucleic Acid Buccal Testing Kit Distribution Agreement With 3D BioMed

March 17, 2020

Amarantus Announces Subsidiary MANF Therapeutics Enters Into Material Transfer Agreement with Dyadic International

February 6, 2020

Amarantus Releases Letter to Shareholders

February 4, 2020

Amarantus Acquires Majority Interest in CBD Wellness Company Hempori

January 30, 2020

Amarantus Completes Sublicense of ESS, MANF and PhenoGuard to Emerald Organic Products

January 2, 2020

Amarantus to Present at 12th Annual LD Micro Main Event

December 9, 2019

Todos To Present At Upcoming 12th Annual LD Micro Main Event

December 6, 2019

Amarantus Subsidiary Elto Pharma Receives Notice of Allowance Covering Use of Eltoprazine Combined with CBD to Treat Parkinson’s Disease

December 4, 2019

Amarantus Announces Issuance of Chinese Patent Covering the Use of MANF and CDNF in Retinal Disorders for Subsidiary MANF Therapeutics

November 21, 2019

Amarantus Provides Recapitalization Update to Shareholders

November 18, 2019

Todos and Amarantus JV Announces Full Enrollment for Clinical Trial of LymPro Alzheimer’s Blood Test Relationship with Amyloid PET

November 14, 2019

Emerald Organic Products to License Therapeutics Portfolio from Amarantus Bioscience Holdings

October 25, 2019

Amarantus Enters Into Agreement to License Diverse Therapeutics Portfolio to CBD-focused Emerald Organic Products

October 24, 2019

Todos Medical and Orot+ Announce First Patient Enrolled in Pre-Commercial Launch Preparations of TM-B1 and TM-B2 Breast Cancer Blood Screening Tests in Europe

September 24, 2019

Amarantus Enters into Letter of Intent with The Alchemists Kitchen to Establish Joint Venture for Research and Commercialization of Hemp and Herbal Smokables for Addiction Treatment Including Smoking Cessation

June 25, 2019

Amarantus Announces Positive Pre-Clinical Data for MANF in Wolfram Syndrome Presented at the 79th Annual Scientific Sessions of the American Diabetes Association

June 18, 2019

Amarantus Announces Issuance of US Patent No. 10,195,251 Covering MANF Treatment of Wolfram's Syndrome, Retinitis Pigmentosa, and Glaucoma for Subsidiary MANF Therapeutics

June 13, 2019

Amarantus to Present at 9th Annual LD Micro Invitational Conference

June 4, 2019

Amarantus Engages Evolution Venture Partners to Evaluate Strategic Alternatives for Expansion into the Emerging Legal Hemp Industry

May 28, 2019

Todos Medical Exercises Option to Acquire Remaining 80.01% of Breakthrough Diagnostics from Amarantus After Review of Alzheimer's Blood Test Data

May 28, 2019

Todos Medical Raises $1,350,500 In Funding and Finalizes Joint Venture Agreement with Amarantus Bioscience

February 28, 2019

Older news releases →

Decks

The 5 newest of 10 decks. Every deck is listed under its year.